Glycine and GlyNAC
Human evidence and registered trials are visible in this field
9 human-evidence records · 0 active trials · 5 visible funding records · 7,911 universities
Canadian Patent Publication
COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND AT LEAST ONE LARGE NEUTRAL AMINO ACID AND/OR CATIONIC AMINO ACID OR PRECURSOR THEREOF
Source-linked patent metadata for COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND AT LEAST ONE LARGE NEUTRAL AMINO ACID AND/OR CATIONIC AMINO ACID OR PRECURSOR THEREOF, including priority, record stage and longevity-topic connections.
Canadian publication snapshot
Application publication visible
This privacy-minimal view describes one official Canadian patent publication. It is not presented as a complete worldwide patent family.
- Representative publication
- CA3196727A1
- Earliest priority
- December 9, 2020
- Latest publication
- June 16, 2022
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Glycine and GlyNAC88% metadata match
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →